Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
AF and CFAE's or complex fractionated atrial electrograms
|
1. Role in A Fib has not been well clarified
2. Conclusion - CFAE plays an important role in the perpetuation of AF. Focal discharge and slow conduction, & pivoting action in CFAE region sustained wave propagation resulting in maintenance of AF |
|
SAFE-T
|
Solatol Amiodarone AF Efficacy Trial -
Conclusion - restoration of Sinus Rhythm was associated with both long & short improvements in QOL, exercise performance and HR |
|
VALUE Trial
|
Compared Valsataran & Amlodipine with new-onset AF and concluded that Valsataran reduced the development of new onset AF
|
|
AF
|
1. Most common form of arrhythmia
2. Affects over 5 million worldwide and 2.3 million in US 3. 43 % of all arrhythmias are AF |
|
What is AF
|
1. Rapid arrhythmia caused when the upper chambers of the heart quiver and do not beat effectively.
2. AV synchrony is lost and this results in reduced atrial kick |
|
A Fib vs. A Flutter
|
1. A Fib - > 300 bpm with irregular V response and is primarily a LA rhythm
2. A flutter >250-400 bpm with regular ventricular response and is primarily a RA response You can be paced out of A Flutter but not out of A Fib |
|
Clincal Consequences of A-Fib
|
1. Rapid V rates
2. Loss of atrial transport 3. Irregular rhythms 4. Stasis with Atrial Thrombi |
|
3 Classifications of A-Fib
|
1. PAF or paroxysmal A - Fib -terminates spontaneously usually in 48 hours
2. Persistent A-Fib - will not terminate spontaneously but can be electrically cardioverted or converted with drugs 3. Permanent A-Fib - will not terminate spontaneously and is refractory to cardioversion |
|
Triggers vs Substrate
|
Triggers responsible primarily for PAF and persistent AF but moves more toward substrate for Permanent AF
|
|
Risk Factors for AF
|
1. Aging
2. Male 3. Hypetension 4. Diabetes 5. Coronary Artery Disease - CAD 6. Diseases for heart valve or structures 7. Congestive Heart Failure |
|
Cardiac Etiologies of A-Fib (Causes
|
1. Valvular Diseases
2. Vascular Diseases - Hypertension, CAD 3. Myocardial Diseases - HF, Cardiomyopathy, Acute MI, Hypertension |
|
Non-Cardiac Etiologies - Causes
|
1. Pulmonary Pathologies - COPD, Embolism, Pneumonia
2. Diabetes 3. Alcohol Abuse 4. Hereditary but incidence is very rare |
|
Lone Atrial Fib:
|
1. Absence of identifiable, cardiovascular, pulmonary or associated systemic disease
2. .8 to 2% of atrial fib patients 3. One study showed patients undergoing electrical cardioversion that 10% had lone AF |
|
Surgical Risk Factors for AF
|
1. Age
2. Male 3. Hypertension 4. Intraaortic balloon pump 5. Pulmonary complications |
|
Echocardiographic Indicators for AF
|
1. Left atrial dialation
2. P Wave duration - pts with SND & PAF - 56% AF free at 30 months with P waves <120 ms 3. P waves > 120 ms & notched is associated with high incidence of AF |
|
Reduce Risk for AF
|
1. Alcohol
2. Beta Blockers 3. Higher cholesterol 4. Higher forced expiratory volume in 1 second |
|
A Fib
|
1. Most common cardiac arrhythmia
2. Over the age of 60 - 4% or 1 / 25 3. Over the age of 80 10% |
|
A Fib Causes in 20th Century
|
1. Hypertension
2. Rheumatic Heart Disease 3. CAD 4. Hyperthyroidism 5. Lone AF |
|
Who gets Atrial Tachyarrhthymias
|
1. Bradycardia patients with a device
2. Over 50% have SND 3. Over 20% have AV Block |
|
AV Dissynchrony
|
Typically not listed as a cause - AF causes loss of AV Synchrony but loss of AV Synchrony may cause AF
|
|
Effects of A -Fib
|
Hemodynamic
1. Loss of AV synchrony or atrial kick 2. Irregular V depolarization 3. Inappropriate increase in rate with exercise 4. Rate related cardiomyopathy Hemostasiologic Activation of platelets and blood coagulation system |
|
Studies
|
1. Danish Study - looked at AAI vs VVI in patients with SND and development of A-Fib - .012
2. PASE (PAcing mode Selection in the Elderly) - compared VVIR to DDIR - QOL was superior in DDD vs VVI, Trend toward reduction in A-Fib in DDD vs. VVI but "ns" 3. CTOPP - Canadian Trial on Physiogic Pacing - compares VVIR and DDIR pacing. Factors favoring development of chronic A-Fib: age >74 years, SND, After 4 years --> 27.1% reduction in chronic A-Fib in DDDR vs VVIR MOST Study - Pacing MOde Selection Trial DDDR vs VVIR - ATI declined to participate in this study. 21% patients with preimplant PAF developed chronic A-Fib Time to develop A Fib VVIR pace 52 days DDIR pace 124 days Study favors DDIR incidence of A Fib increased in all of these studies... |
|
AF Mechanisms
|
a. 1896 Englemann proposed AF could result from a single atrial focus. Jais showed (1990s) AF cure by ablation of a single focus
b. Moe proposed multiple wavelet theory which was later confirmed by Allessie (1980s) by mapping experiments |
|
AF - Reentrant Mechanism
|
general agreement that AF is a reentrant rhythm but precise mechanisms for its initiation and maintenance have not been resolved
|
|
AF: initiation, perpetuation, & ablation
|
1. 2 major factors for AF - focal drivers and wavelet reentry
2. Primary drivers are active in PAF and are often located in PV, SVC, vien of Marshall, and CS 3. Successful ablation requires elimination of drivers as well as breaking up the wavelets |
|
AF Structural Changes
|
1. Structural changes with aging and fibrosis
2. Changes more extensive in AF patients 3. Lifetime risk of developing AF is 25% 4. Changes in the myocardial sleeves on the PVs. |
|
Structural Remodeling
|
1. Chronic pressure overload can lead to structural changes resulting in interstitial fibrosis
2. Fibrosis leads to anistropy which leads to uncoupling of side to side connections of parallel fibers, slow conduction & conduction block |
|
Role of Angiotensin II in AF
|
AF leads to fibrosis which increases with duration
Strongest triggers for fibrosis in dilation most often seen with: 1. CHF 2. CAD 3. Hypertension ANG II may contribute to AF by: 1. Activation of intracellular pathways leading to hypertrophy & dilation 2. Aldosterone production enhancing fibrosis |
|
Focal AFib
|
1. Initiation and maintenance of AF are due to rapidly discharging focal tachycardia
2. Mechanism is either abnormal automaticity or triggered activity because it's not inducible by NIPS 3. PV's are typically the source of ectopic foci and are an important source of ectopic beats initiating frequent PAF. These foci respond to treatment with RF ablation |
|
Focal Ablation
|
1. Atrial foci can be identified in many patients with PAF
2. They may be amenable to ablation effectively curing or delaying development of chronic atrial fib |
|
Challenge of PV Ablation
|
1. Difficult to map & time consuming - as each PV requires mapping
2. Pulmonary vein stenosis 3. Endothelial injury with thrombosis and embolism 4. Predisposition to other arrhythmias associated with ablation scars. Hassaguerre (38%) recurrence rate after ablation |
|
AF Substrates
|
not all patients show PV dilation or PV myocardial sleeves emphasizes the role of non-PV triggers for AF
|
|
Other SVTs as AF Initiators
|
SVTs can induce AF by means of mechanoelectrical feedback.
Increase in atrial pressure & stretch alters atrial refractoriness & increases dispersion of refractoriness. Helps to create substrate for reentry and Atrial Natural peptide release |
|
Conclusion:
|
1. AF is heterogeneous disease with multiple etiologies and mechanisms
2. AF may arise from rapid discharging foci emanating from PVs or substrate abnormalities that promote multiple wavelets of reentry. 3. Electrophysiologic and structural remodeling form the substrate for reentry |